Search

Our tertiary ALS Centre represents a national reference Centre for the diagnosis, treatment and clinical research of motor neuron diseases. Individuals with ALS from Puglia and other Italian regions cared in a multidisciplinary approach. Our Centre also participates to international clinical protocols.

After an interim analysis, Corcept Therapeutics announced that their phase 2 study showed no change on the primary endpoint, the ALSFRS-R score. However, there does appear to be an effect on survival, which is why Corcept will continue the open-label phase (OLE).

Two weeks ago, the 35th edition of the International Symposium on ALS/MND took place. For this conference, researchers, healthcare professionals and patients (organisations) gathered from all over the world in Montréal, Canada.

The International Symposium is the biggest annual conference dedicated to ALS and MND research.

Sign up for our free newsletter

TRICALS provides two service package options: MAGNET, a complete all-in-one package, and TRICALS Support, which lets you select and combine individual services to tailor our support to your needs.

INARC hosts a full-day meeting during ENCALS 2025 on June 3th

INARC satellite meeting June 3th, ENCALS 2025